Tags:BioTechCauseDeviceEquipmentHumanManufacturingMedicalMedTechTechnology
VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for YAG laser capsulotomy after surgery, our device has the potential to revolutionise cataract surgery in both the human and veterinary markets.
Location: United Kingdom, England
Member count: 1-10

Investors 3

Mentions in press and media 1

DateTitleDescriptionCategoryAuthorSource
16.05.2019MassChalle...May 15, 2019 Renens – MassChal...--masschalle...